Applied Statistics

Biology: Novartis Pharmaceuticals

Total Score People Score Events Score
35 28 28
Date Event Presentation Speakers
September 4, 2016 10th Vaccine Congress OPENING PLENARY SESSION: Vaccinology in the 21st century Rino Rappuoli
April 2, 2016 Modern Phenotypic Drug Discovery: Defining the Path Forward Target/MOA Identification/Deconvolution Andreas Bender
October 31, 2013 (T1) Keystone Symposia: Advancing Vaccines in the Genomics Era Immunology of Vaccination in the Young and Elderly Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting Rino Rappuoli
April 6, 2013 AACR Annual Meetings Target Validation by Chemical Probes/Designer Chemical Probes and Phenotypic Approach to Drug Discovery Chairperson: Michael A. Foley, Broad Institute of MIT and Harvard, Cambridge, MA John Tallarico
New Approaches to Drug Discovery Chairperson: William R. Sellers, Novartis Institutes for BioMedical Research, Cambridge, MA Eric Martin
December 4, 2012 4th World Epigenetics Summit Epigenetics - Impact for Translational and Drug Safety Sciences Remi Terranova
May 10, 2011 The Molecular and Cellular Mechanisms, Regulating Skeletal Muscle, Development and Regeneration Signaling pathways that mediate skeletal muscle atrophy and hypertrophy David Glass
November 3, 2010 Eighth Annual RNAi for Functional Screens Synthetic Lethal siRNA Screens Using Preclinical Compounds Alex Gaither
June 1, 2010 Emerging Themes in Infection Biology Vaccines: a health insurance of the 21st century Rino Rappuoli
May 19, 2010 Towards Personalized Cancer Medicine The Discovery and Application of Cancer Therapeutics in the Genomic Era William R Sellers
November 2, 2009 Track 2: Third Annual HDAC Inhibitors A Clinical Update on the Development of Panobinostat Samit Hirawat
November 2, 2009 Track 1: Seventh Annual RNAi for Screening Cellular Pathways and Targets Using Targeted siRNA Screens to Identify Novel Regulators of Viral Replication Alex Gaither
Chairperson’s Remarks Alex Gaither
October 6, 2009 Next Generation Technologies for Protein Science Development of a Novel Gateway-based Vector System for Efficient, Multiparallel Protein Expression in Escherichia coli, Insect and Mammalian Cells. Felix Freuler
August 5, 2009 Drug Safety Strategies to De-Risk Compounds in silico Methods in Drug Safety Josef Scheiber
June 22, 2009 Symposium: Light Microscopy meets Structural Biology Quantification of the dynamics of protein complex formation in vivo Dr. Hans Peter Knopf
June 10, 2009 Second Annual Hepatotoxicity and Drug Safety KEYNOTE PANEL DISCUSSION Laszlo Urban
June 4, 2009 Structure-Based Drug Design Main Conference Indresh K. Srivastava
May 18, 2009 Fifth Annual Biomalpar Conference on Biology and Pathology of the Malaria Parasite Keynote lecture: ELIZABETH A. WINZELER
February 9, 2009 Immunogenicity for Biologics 2009 Parallel analysis of exposure and immunogenicity by Biacore in pre-clinical studies Annette Zaar
January 26, 2009 7th Annual Partnering with Central Labs B2 : The Use of Imaging Biomarkers in Phase I/II trials Haren Rupani
Technical Hot Topics Haren Rupani
Track A : Improve Patient Care, Transparency and Process Efficiency in Global Studies Scott Sawicki
Track A : Central Lab Cost Drivers and Logistics Discussion Forum Scott Sawicki
October 22, 2008 Targeting Diabetes With Novel Therapeutics Chairperson’s Remarks Jesper Gromada
FGF-21 for the Treatment of Type 2 Diabetes Jesper Gromada
September 29, 2008 Genomic Biomarkers Biomarker Application in Oncology Clinical Development Michael Shi
March 25, 2008 PATHWAY ANALYSIS Predictive Value of in Vitro Safety Studies Willi Suter
Integrating High-Throughput Data via Pathway-Centric Analyses Joseph D Szustakowski
February 18, 2008 Fragment-based Lead Discovery Conference Successes and Surprises with Fragments Wolfgang Jahnke
Morning Session: Methods & Emerging Technologies, Part I Wolfgang Jahnke
In vivo Incorporation of NMR-active Unnatural Amino Acids Bernhard Geierstanger
January 6, 2008 Structural Genomics and its Applications to Chemistry, Biology and Medicine Workshop 1: Applications of Structural Genomics for Structural Biology Heath E. Klock
December 1, 2007 47TH American Socieity of Cell Biology Solving Cell Culture Problems: Lori Ryan
October 11, 2007 Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Drug Repositioning Summit) (12:30-17:15) Jeremy S. Caldwell, Laszlo Urban
SCREENING AGAINST MULTIPLE TARGETS: Integrative In Vitro Safety Pharmacology Profiling to Predict Clinical Adverse Effects (15:45-16:15) Laszlo Urban
SCREENING AGAINST MULTIPLE TARGETS: Automated Robotic Molecular Profiling in Cells for New Therapeutic Directions (14:15-14:45) Jeremy S. Caldwell
SELECTING LEADS AND DETECTING ADVERSE ACTIVITY: Compound Profiling by Predicting On-Target Activities, Compound Promiscuity and Adverse Drug Reactions (16:00-16:30) Andreas Bender
October 10, 2007 Drug Repositioning Summit: Finding New routes to success (Oct 10-11) SCREENING AGAINST MULTIPLE TARGETS: Automated Robotic Molecular Profiling in Cells for New Therapeutic Directions (14:15-14:45) Jeremy S. Caldwell
SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Compound Profiling) (13:30-17:15) Jeremy S. Caldwell, Laszlo Urban
SCREENING AGAINST MULTIPLE TARGETS: Broad-Scale In Vitro Pharmacology Profiling to Predict Clinical Adverse Effects and for ADME Profiling (15:45-16:15) Laszlo Urban
September 27, 2007 Protein Expression Europe (Sep 27-28) Drug Discovery Applications (13:00-15:15) Lorenz Mayr
Drug Discovery Applications: Miniaturization and Automation of Protein Expression for High-Throughput Screening and Structural Biology (13:15-13:45) Lorenz Mayr
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.